Laboratory for research of transfusion infections
Detection of markers of Hemotransfusion infections is carried out in two stages:
Serological testing (antibody/antigen detection)
Carried out by immunohemiluminescent analysis (IHLA) for antibodies to HIV-1, HIV-2 and HIV P24 antigen; surface antigen of hepatitis B virus; antibodies to hepatitis C virus; antibodies to pale Treponema (syphilis); brucellosis markers are determined in the Wright-Heddelson reaction; all samples with a negative result pass the second stage of testing.
Molecular genetic testing (determination of RNA/DNA of the pathogen).
To isolate hepatitis B virus DNA, HIV 1, 2 RNA and hepatitis C, polymerase chain reaction (PCR) is performed.
The laboratory uses only high-tech and high-precision equipment that meets the latest global trends in laboratory diagnostics.
Stages of the study of infectious markers are carried out on closed-type automatic analyzers: "Architect" (produced by Abbott of the USA), PCR in the system "Cobass201" (produced by Roche of Switzerland), a full range of immunohematological studies of closed-type "IH-1000" (produced by Bio-Rad of France), "ORTHO VISION" "AUTOVUE." It is carried out on automatic analyzers" Innova " (ortho-ClinicalDiagnostics), using gel and column agglutination methods. The results of the study are automatically entered into the Infodonor information computer system, which allows you to completely eliminate the error in identifying donors.
In addition to the above-mentioned tests, the laboratory provides services on a paid and contractual basis in accordance with the approved price list.